Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

This publication has 28 references indexed in Scilit:

• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery
  Kidney International, 1999
• Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure
  Kidney International, 1998
• Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart Disease
  Scandinavian Journal of Urology and Nephrology, 1996
• Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles
  The American Journal of Cardiology, 1994
• Epidemiology of heart failure in the United States
  American Heart Journal, 1993
• Therapy with Recombinant Human Erythropoietin Reduces Cardiac Size and Improves Heart Function in Chronic Hemodialysis Patients
  American Journal of Nephrology, 1991
• Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
  The American Journal of Cardiology, 1990
• Measurement of renal function in chronic renal disease
  Kidney International, 1990
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
  New England Journal of Medicine, 1986